Acute treatment with valproic acid and L-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats
dc.contributor.author | Castelo-Branco, G | en_US |
dc.contributor.author | Stridh, P | en_US |
dc.contributor.author | Guerreiro-Cacais, AO | en_US |
dc.contributor.author | Adzemovic, MZ | en_US |
dc.contributor.author | Falcao, AM | en_US |
dc.contributor.author | Marta, M | en_US |
dc.contributor.author | Berglund, R | en_US |
dc.contributor.author | Gillett, A | en_US |
dc.contributor.author | Hamza, KH | en_US |
dc.contributor.author | Lassmann, H | en_US |
dc.contributor.author | Hermanson, O | en_US |
dc.contributor.author | Jagodic, M | en_US |
dc.date.accessioned | 2016-08-31T11:26:53Z | |
dc.date.available | 2014-08-11 | en_US |
dc.date.issued | 2014-11 | en_US |
dc.date.submitted | 2016-08-15T15:33:06.999Z | |
dc.identifier.issn | 0969-9961 | en_US |
dc.identifier.other | 10.1016/j.nbd.2014.08.019 | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/14910 | |
dc.description.sponsorship | This work was supported by grants from the Swedish Research Council (MJ (K2008-66X-20776-01-4 and K2012-99X-20776-05-3)), OH (2011-3457) and GCB (K2011-80P-21816-01-4 and K2011-80X- 21817-01-4)), Harald and Greta Jeanssons Foundation (MJ), Swedish Association for Persons with Neurological Disabilities (MJ), ÅkeWibergs Foundation (MJ), Åke Löwnertz Foundation (MJ), Swedish Brain Foundation (MJ and GCB), David and Astrid Hagélen Foundation (GCB), Swedish Society for Medical Research (GCB), Swedish Society of Medicine (GCB), Socialstyrelsen (MJ), Karolinska Institutet funds (MJ and GCB), Marie Curie Integration Grant, Seventh Framework Programme, European Union (GCB, PCIG12-GA-2012-333713)), Neuropromise LSHM-CT-2005-018637 (MZA, HL) and Theme Center for Regenerative Medicine at Karolinska Institutet (OH). | en_US |
dc.format.extent | 220 - 233 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | NEUROBIOLOGY OF DISEASE | en_US |
dc.rights | CC BY license | |
dc.subject | Multiple sclerosis | en_US |
dc.subject | Experimental autoimmune encephalomyelitis | en_US |
dc.subject | Epigenetics | en_US |
dc.subject | Histone deacetylases | en_US |
dc.subject | Thyroid hormone | en_US |
dc.subject | Neuroinflammation | en_US |
dc.subject | Oligodendrocyte precursor | en_US |
dc.subject | Myelin | en_US |
dc.subject | Immune system | en_US |
dc.subject | T cells | en_US |
dc.title | Acute treatment with valproic acid and L-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats | en_US |
dc.type | Article | |
dc.rights.holder | © 2014 The Authors. Published by Elsevier Inc | |
dc.identifier.doi | 10.1016/j.nbd.2014.08.019 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342549900022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 71 | en_US |